Measure2-a | All Participants2-b (n = 76) | Expt. 12-c | Expt. 2,2-d Dose Effects | Expt. 3,2-e Suppression of Withdrawal | Expt. 4,2-f Duration of Exposure (No. Days) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
100 | 300 | 600 | 300 | 200 | 100 | 50 | 25 | 0 | 1 | 3 | 7 | 14 | |||
300 versus 0 | 300 versus 0 | versus 0 | versus 300 | 300 versus 0 | |||||||||||
Headache | 0.001 | 0.001 | 0.005 | 0.001 | 0.001 | 2-g | 0.001 | 0.007 | 0.007 | ||||||
Cluster scales | |||||||||||||||
Headache/poor mood | 0.001 | 0.017 | 0.006 | 0.031 | 0.018 | 0.007 | 0.046 | ||||||||
Activity/alertness (↓) | 0.01 | 0.018 | 0.014 | 0.016 | 0.028 | 0.034 | 0.019 | 0.003 | |||||||
Physical symptoms | 0.029 | ||||||||||||||
Tiredness | 0.001 | 0.003 | 0.011 | 0.019 | 0.001 | 0.043 | 0.02 | 0.031 | 0.04 | 0.002 | 0.001 | 0.003 | |||
Flu-like symptoms | 0.001 | 0.041 | 0.030 | ||||||||||||
POMS2-h | |||||||||||||||
Fatigue | 0.001 | 0.036 | 0.015 | 0.023 | 0.012 | 0.017 | 0.04 | 0.007 | 0.001 | 0.002 | 0.014 | ||||
Confusion-Bewilderment | 0.03 | 0.028 | 0.027 | 0.007 | |||||||||||
Vigor (↓) | 0.001 | 0.025 | 0.013 | 0.005 | 0.006 | ||||||||||
Friendly (↓) | 0.009 | 0.043 | 0.006 | ||||||||||||
Total mood disturbance | 0.04 | 0.011 | 0.012 | 0.013 | 0.027 |
↵2-a For all significant effects shown, substitution of placebo or lower caffeine doses (expt. 3) increased all measures relative to caffeine except for Activity/Alertness, Vigor (POMS), and Friendly (POMS), which were decreased significantly, as indicated by down arrow.
↵2-b Comparison between last 2 days of caffeine (300 mg/day) and first 2-day placebo substitution (0 mg/day) across all four experiments.
↵2-c Comparison between last 2 days of caffeine (300 mg/day) and 2-day placebo substitutions for data collapsed across two dosing intervals and three replications.
↵2-d Comparison between last 2 days of each caffeine maintenance dose and corresponding 2-day placebo substitution.
↵2-e Comparison between last 2 days of caffeine (300 mg/day) and corresponding 2-day dose substitution.
↵2-f Comparison between last 2 days of 14-day caffeine condition (300 mg/day) and first 2 days of placebo substitution after each of the caffeine exposures (i.e., 1, 3, 7, or 14 days of 300 mg/day caffeine).
↵2-g No value indicates comparison was not statistically significant at p ≥ .05.
↵2-h Three POMS scales (Anger-Hostility, Depression-Dejection, Tension-Anxiety) are not shown in this table because they did not show significant caffeine withdrawal effects in any experiment.